ICD-10-CM Billable Code

K71.0

Toxic liver disease with cholestasis

Clinical Classification Guidelines

Inclusion Terms

  • Cholestasis with hepatocyte injury
  • 'Pure' cholestasis

Medical Intelligence & Overview

Toxic liver disease with cholestasis, classified under ICD-10 code K71.0, is a liver condition caused by exposure to harmful substances leading to liver cell injury and impaired bile flow. Often referred to as 'pure' cholestasis, this condition results in the retention of bile components within the liver, which can cause various symptoms and potential complications if not managed appropriately. Recognizing the causes, symptoms, and potential treatment options is essential for understanding this specific liver disorder.

Causes & Symptoms

Clinical Causes: Exposure to hepatotoxic chemicals or toxins such as industrial solvents, certain medications, or chemicals in herbal remedies. Ingestion of excessive alcohol over a short period or chronic alcohol abuse. Prolonged exposure to certain environmental toxins or contaminated substances. Accidental or intentional ingestion of toxic substances leading to liver injury. Use of medications known to cause cholestasis as a side effect, including some antibiotics, anabolic steroids, and hormone therapies.

Key Symptoms: Jaundice (yellowing of the skin and eyes) Dark urine caused by excess bilirubin Pale or clay-colored stools due to decreased bile flow Itching all over the body (pruritus) Fatigue and weakness Abdominal pain or discomfort, particularly in the upper right side Nausea and loss of appetite Unexplained weight loss in some cases

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a combination of clinical evaluation and laboratory tests. Blood tests such as liver function tests (LFTs) reveal elevated levels of bilirubin and other liver enzymes indicative of cholestasis. Imaging procedures like ultrasound, MRI, or CT scans help assess liver structure and rule out obstructions or other causes of bile flow disruption. In some cases, a liver biopsy may be performed to examine liver tissue for damage and confirm the diagnosis of toxic injury with cholestasis.

Treatment Protocols: Treatment primarily focuses on removing or avoiding the hepatotoxic substances causing the condition. Supportive care includes hydration, nutritional support, and medications to relieve symptoms like itching. In cases where specific toxins are identified, chelation or other detoxification methods may be employed. Monitoring liver function regularly is essential to assess recovery. If the liver damage is severe or progressive, hospitalization and advanced interventions may be necessary. Prevention involves avoiding known toxins and careful medication management under medical supervision.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is K71.0 a billable ICD-10 code?
Yes, K71.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report K71.0?
Clinical documentation must specify the nature of Toxic liver disease with cholestasis and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

toxic cholestasis liver disease